PT-141 (bremelanotide) is a melanocortin receptor agonist that acts centrally in the brain to increase sexual desire and improve erectile response, independent of the vascular pathway targeted by Cialis or Viagra. Men use it subcutaneously at doses typically between 0.5 and 2 mg, taken 30 to 90 minutes before intimacy. Threads in this tag cover titration to find a tolerated dose, common side effects like nausea and facial flushing, comparison with PDE5 inhibitors, sourcing and legal considerations, and why PT-141 often works for men who have not responded to other ED treatments.